@article{fd8aee5b27b442dcbc6ed988ba418c0e,
title = "Treatment Strategies in Metastatic Renal Cancer: Dose Titration in Clear Cell Renal Cell Carcinoma",
author = "Brown, {Janet E.} and Symeonides, {Stefan N.}",
note = "Funding Information: Conflicts of interest: Janet E. Brown has received personal fees for advisory board membership from Novartis, MSD, Ipsen, and BMS, nonpromotional speaker meeting fees and meeting attendance support from Ipsen, and an institutional research grant from AstraZeneca. Stefan N. Symeonides has received institutional advisory board fees from BMS, Boxer Capital, Duke St Bio, Eisai, Ellipses, EUSA, Medannex, Merck Serono, MSD, Pfizer, and Vaccitech; institutional research funding from MSD and Verastem; institutional fees for nonpromotional educational speaker meetings from BMS, EUSA, Ipsen, and MSD; and conference attendance support from BioNTech, BMS, EUSA, Ipsen, and MSD.",
year = "2022",
month = aug,
day = "11",
doi = "10.1016/j.eururo.2022.04.018",
language = "English",
volume = "82",
pages = "293--294",
journal = "European Urology",
issn = "0302-2838",
publisher = "Elsevier",
number = "3",
}